We have to remember that it is not a zero sum game, that when we add a pharmaceutical benefit, it does not simply and only add to the costs of Medicare. Because in many ways, using a pharmaceutical product, using a medicine, is the least expensive way to treat an illness as compared to surgery. I have a chart here on my left that demonstrates an instance of that. This is the cost of treating stroke patients. If we use a treatment that consists of a pharmaceutical approach, which uses a clot-busting drug, it costs about $1,700 to treat that patient on an annual basis. Yet, by doing that, we are keeping that patient from having to go through the pain and the expense of rehab and often nursing care. So the difference here is that we save $6,100 that otherwise Medicare would have been paying for.
Editor's note · Context
Discussing the cost-effectiveness of pharmaceutical benefits in Medicare.
Share
More from James P. Greenwood
Madam Chairman, since 1969 when the program was developed with the help of the United States of America, United Nations Family Planning Fund has met an incredible need. That need is that in developing countries in Africa and Asia and…
the previous speaker and most of the opponents of this bill have acknowledged that we have a crisis, a crisis that has to be resolved, and unfortunately, they have not articulated an alternative to our proposal, only their criticisms of…
Debates as the one we are having today always focus on the differences between us; and there are, in fact, differences between us. We who offer this substitute amendment believe that the 90 percent of abortions that occur in the first…
it is fitting that this new hour follows that last 5-minute presentation which was a perfectly classic example of partisan rhetoric aimed more to gain political favor than to shed light on an issue. What we are going to do for the next…





